Pacific Biosciences and Asuragen Collaborate to Develop Assays for Carrier Screening and other Applications Based on SMRT Sequencing Technology and AmplideX PCR Chemistry

Joint research effort will lead to molecular assays that can improve variant detection and access difficult-to-sequence regions of the human genome Joint research effort will lead to molecular assays that can improve variant detection and access difficult-to-sequence regions of the human genome Read more

Rozlytrek, Roche’s first tumour-agnostic therapy, approved in Europe for people with NTRK fusion-positive solid tumours and for people with ROS1-positive advanced non-small cell lung cancer

Rozlytrek has shown durable responses across multiple tumour types, including cancer that has spread to the brain This approval shows the value of combining genomic profiling with precision medicine to offer patients with rare and hard-to-treat cancers a personalised treatment option              Basel, 03 August 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that... Read more

FDA approves Roche’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanoma

Basel, 31 July 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq® (atezolizumab) plus Cotellic® (cobimetinib) and Zelboraf® (vemurafenib) for the treatment of BRAF V600 mutation-positive advanced melanoma patients.  The safety profile observed in the Tecentriq combination was consistent with the known safety profiles... Read more

Brooks Automation Reports Results of its Third Quarter of Fiscal 2020, Ended June 30, 2020, and Announces Quarterly Cash Dividend

Brooks Automation Reports Results of its Third Quarter of Fiscal 2020, Ended June 30, 2020, and Announces Quarterly Cash Dividend Continued Revenue Growth and Earnings Expansion on Solid Execution Across Both Segments CHELMSFORD, Mass., July 30, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today reported financial results for the third fiscal quarter, ended June... Read more

HORIBA announces the launch of EasyImage, a new imaging tool for Raman microscopy

Expert level Raman Images for Everyone with EasyImage™ Palaiseau, Saclay Campus, France, July 30th, 2020 –  HORIBA, a global leader in measurement and analysis solutions for advanced research and industry, and the world leader in Raman microscopy and nanoscopy, is thrilled to announce the launch of EasyImage™, a new imaging tool for Raman microscopy. EasyImage™ is a... Read more

Thermo Scientific nProber IV Delivers Faster, Easier Failure Analysis Process for Semiconductor Labs

Thermo Scientific nProber IV Delivers Faster, Easier Failure Analysis Process for Semiconductor Labs New platform provides faster identification of defects that impact device performance HILLSBORO, Ore., July 30, 2020 /PRNewswire/ — Thermo Fisher Scientific today released the Thermo Scientific nProber IV nanoprober platform, a fault isolation system used by semiconductor fabs to precisely locate and... Read more

Bruker Launches Revolutionary High-Speed AFM System for Single-Molecule Applications

JPK NanoRacer® Follows Molecular Dynamics in Real Time at 50 Frames per Second BERLIN–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the release of the NanoRacerhigh-speed AFM system. With an unprecedented imaging speed of 50 frames per second, this sets a new milestone in high-speed scanning capabilities to enable true real-time visualization of dynamic biological... Read more

GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI)

Amersham, UK, Minnesota, USA, and Melbourne, Australia— 30 July 2020 — GE Healthcare and Osprey Medical Inc. (ASX:OSP) (Osprey) today announced a strategic alliance under which GE Healthcare will exclusively distribute Osprey’s product portfolio in Europe, Russia, Middle East, Africa, Central Asia and Turkey.  Osprey’s DyeVert™ contrast minimization devices, complemented by GE Healthcare’s range of... Read more